Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.

Liekens S, Bronckaers A, Pérez-Pérez MJ, Balzarini J.

Biochem Pharmacol. 2007 Dec 3;74(11):1555-67. Epub 2007 May 16. Review.

PMID:
17572389
2.

Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.

Tsukagoshi S, Saga Y, Suzuki N, Fujioka A, Nakagawa F, Fukushima M, Suzuki M.

Int J Oncol. 2003 May;22(5):961-7.

PMID:
12684660
3.

The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Bronckaers A, Gago F, Balzarini J, Liekens S.

Med Res Rev. 2009 Nov;29(6):903-53. doi: 10.1002/med.20159. Review.

PMID:
19434693
4.

Thymidine phosphorylase: a two-face Janus in anticancer chemotherapy.

Focher F, Spadari S.

Curr Cancer Drug Targets. 2001 Aug;1(2):141-53. Review.

PMID:
12188887
5.

Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study.

Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL.

J Pathol. 1995 Jun;176(2):183-90.

PMID:
7636628
7.

The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.

Akiyama S, Furukawa T, Sumizawa T, Takebayashi Y, Nakajima Y, Shimaoka S, Haraguchi M.

Cancer Sci. 2004 Nov;95(11):851-7. Review.

8.

Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.

Kitazono M, Takebayashi Y, Ishitsuka K, Takao S, Tani A, Furukawa T, Miyadera K, Yamada Y, Aikou T, Akiyama S.

Biochem Biophys Res Commun. 1998 Dec 30;253(3):797-803.

PMID:
9918807
9.

Thymidine phosphorylase and fluoropyrimidines efficacy: a Jekyll and Hyde story.

Ciccolini J, Evrard A, Cuq P.

Curr Med Chem Anticancer Agents. 2004 Mar;4(2):71-81. Review.

PMID:
15032715
10.

Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.

Uchimiya H, Furukawa T, Okamoto M, Nakajima Y, Matsushita S, Ikeda R, Gotanda T, Haraguchi M, Sumizawa T, Ono M, Kuwano M, Kanzaki T, Akiyama S.

Cancer Res. 2002 May 15;62(10):2834-9.

11.

Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications.

Pérez-Pérez MJ, Priego EM, Hernández AI, Camarasa MJ, Balzarini J, Liekens S.

Mini Rev Med Chem. 2005 Dec;5(12):1113-23. Review.

PMID:
16375757
12.

Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumor angiogenesis and macrophage infiltration in colorectal cancer.

Matsumura M, Chiba Y, Lu C, Amaya H, Shimomatsuya T, Horiuchi T, Muraoka R, Tanigawa N.

Cancer Lett. 1998 Jun 5;128(1):55-63.

PMID:
9652793
13.

Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human gallbladder lesions.

Yamamoto S, Kitadai Y, Tsuchida A, Sasaki T, Matsubara K, Kajiyama G.

Eur J Cancer. 2000 Jan;36(2):257-63.

PMID:
10741286
14.

Role of thymidine phosphorylase in biomodulation of fluoropyrimidines.

Morita T, Matsuzaki A, Suzuki K, Tokue A.

Curr Pharm Biotechnol. 2001 Sep;2(3):257-67.

PMID:
11530879
15.

The rôle of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective.

Cole C, Foster AJ, Freeman S, Jaffar M, Murray PE, Strafford IJ.

Anticancer Drug Des. 1999 Oct;14(5):383-92. Review.

PMID:
10766293
16.

Novel nonsubstrate inhibitors of human thymidine phosphorylase, a potential target for tumor-dependent angiogenesis.

Focher F, Ubiali D, Pregnolato M, Zhi C, Gambino J, Wright GE, Spadari S.

J Med Chem. 2000 Jun 29;43(13):2601-7.

PMID:
10891120
17.

Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro.

Igawa H, Fujieda S, Kimura Y, Sugimoto C, Tanaka N, Ohtsubo T, Kato Y, Saito H.

Oncol Rep. 2003 Jul-Aug;10(4):967-71.

PMID:
12792754
18.

Expression of thymidine phosphorylase correlates with microvessel density in prostate cancer.

Kataoka A, Yuasa T, Kageyama S, Iwaki H, Higuchi K, Tanaka T, Okada Y, Yoshiki T.

Oncol Rep. 2005 Apr;13(4):597-600.

PMID:
15756429
20.

The role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor behavior.

Bijnsdorp IV, de Bruin M, Laan AC, Fukushima M, Peters GJ.

Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):681-91. doi: 10.1080/15257770802143988. Review.

PMID:
18600526

Supplemental Content

Support Center